Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Core EBITDA Margin

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) -8.91-24.46-22.972.447.39

What is the latest Core EBITDA Margin ratio of OXYGENTA PHARMACEUTICAL ?

The latest Core EBITDA Margin ratio of OXYGENTA PHARMACEUTICAL is -8.91 based on Mar2025 Standalone results.
Year Core EBITDA Margin
Mar2025-8.91
Mar2024-24.46
Mar2023-22.97
Mar20222.44
Mar20217.39

How is Core EBITDA Margin of OXYGENTA PHARMACEUTICAL Trending?

Years Core EBITDA Margin % Change
Mar2025 -8.91
Negative
Mar2024 -24.46
Negative
Mar2023 -22.97
Negative
Mar2022 2.44
-66.98
Mar2021 7.39 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Core EBITDA Margin ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹203.5 Cr -1.1% -7% -39.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,708.0 Cr -2.9% -1.8% -2.5% Stock Analytics
DIVIS LABORATORIES ₹171,975.0 Cr 2.1% 0.2% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,619.0 Cr 0.5% 2.2% 11.2% Stock Analytics
CIPLA ₹122,539.0 Cr 0.7% -0.8% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,741.0 Cr -0.1% 2.5% 2.5% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-1.1%

-7%

-39.6%

SENSEX

-0.4%

-0.3%

3.9%


You may also like the below Video Courses